RxDoctor Payments Data

Jessica Collins

Family · Petersburg, INNPI 1598161143

Payments from drug & device makers

$686in general payments, 2019–2025

Across 46 payments — averaging $14.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$291
  • Novartis$74
  • Novo Nordisk$45
  • Pfizer$27
  • AstraZeneca$25
  • Nestle Healthcare Nutrition Inc.$22
  • plus $203 from 14 others

What the payments were for

  • Food & beverage$67598%
  • Education$122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$686 in reported general payments places this provider in the 60th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$46,084
Medicare patients
187
Services billed
874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide70$71,582
JardianceEmpagliflozin34$30,752
EliquisApixaban60$28,401
LinzessLinaclotide32$17,415
FarxigaDapagliflozin Propanediol38$13,930
Spiriva RespimatTiotropium Bromide22$11,500
SymbicortBudesonide/Formoterol Fumarate28$7,238
Spiriva HandihalerTiotropium Bromide12$6,367
MyrbetriqMirabegron26$5,877
Fluticasone-SalmeterolFluticasone Propion/Salmeterol59$5,677
Albuterol Sulfate HfaAlbuterol Sulfate152$4,607
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$4,503
Fluticasone-Salmeterol HfaFluticasone Propion/Salmeterol12$3,900
Atorvastatin Calcium305$1,834
Gabapentin128$1,648

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$45$71,58270 claims
PfizerEliquis$27$28,40160 claims
AstraZenecaFarxiga, Symbicort$25$21,16866 claims
AbbVieLinzess$291$17,41532 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,392 family providers in Indiana.

Other family in Petersburg

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →